Measuring Surgical Recovery After Radical Cystectomy
ConditionBladder Cancer
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorM.D. Anderson Cancer Center
About this trial
The intent of this study is to establish a registry of post-surgical outcomes in patients undergoing radical cystectomy at MD Anderson Cancer Center and the collaborating institutions. The goals of this initiative are to obtain a detailed baseline of multiple patient-reported outcomes (PRO) and clinician-reported outcomes (CRO) as well as various presenting conditions associated with them, so that future quality improvement interventions can be evaluated accurately as to their relative contribution to improved outcomes.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
None
Disqualifiers
None
Trial population
Bladder cancer patients undergoing radical cystectomy at the MD Anderson Cancer Center and the collaborating centers.
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
Post-Operative Recovery Registry
BehavioralMulti-institutional prospective database of patients with bladder cancer undergoing radical cystectomy.
Treatment groups
2,000 Participants
are divided into 1 treatment groupGroup A: Bladder Cancer Patients Undergoing Radical Cystectomy1 intervention
Trial outcomes
Primary outcomes
1
Post-Surgical Outcomes in Patients Undergoing Radical Cystectomy
Post-surgical outcomes determined from patient-reported assessment of symptom burden using the MD Anderson Symptom Inventory (MDASI-BLC form).
Time frame
3 monthsSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov